var data={"title":"Vitamin C (ascorbic acid): Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Vitamin C (ascorbic acid): Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/5671?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=vitamin-c-ascorbic-acid-patient-drug-information\" class=\"drug drug_patient\">see &quot;Vitamin C (ascorbic acid): Patient drug information&quot;</a> and <a href=\"topic.htm?path=vitamin-c-ascorbic-acid-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Vitamin C (ascorbic acid): Pediatric drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F136900\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Acerola C 500 [OTC];</li>\n      <li>Asco-Tabs-1000 [OTC];</li>\n      <li>Ascocid [OTC];</li>\n      <li>Ascocid-ISO-pH [OTC];</li>\n      <li>BProtected Vitamin C [OTC];</li>\n      <li>C-500 [OTC];</li>\n      <li>C-Time [OTC];</li>\n      <li>Cemill SR [OTC];</li>\n      <li>Cemill [OTC];</li>\n      <li>Chew-C [OTC];</li>\n      <li>Fruit C 500 [OTC];</li>\n      <li>Fruit C [OTC];</li>\n      <li>Fruity C [OTC];</li>\n      <li>Mega-C/A Plus [DSC];</li>\n      <li>Ortho-CS 250 [DSC];</li>\n      <li>Vita-C [OTC];</li>\n      <li>VitaChew Vit C Citrus Burst [OTC]</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F136901\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>Ascor L 500;</li>\n      <li>Vitamin C</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F136950\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Vitamin, Water Soluble</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F136905\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Ascorbic acid deficiency:</b> IM, IV, SubQ: 70 to 150 mg daily is an average protective dose; doses 3 to 5 times the RDA may be adequate for conditions with increased requirements.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Burns:</b> IM, IV, SubQ: 1 to 2 g daily for severe burns; dose may be determined by extent of tissue injury</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Parenteral nutrition, maintenance requirement: </b>IV: 200 mg/day (ASPEN [Vanek 2012]).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Scurvy:</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">IM, IV, SubQ: 300 to 1,000 mg daily; dose and duration of therapy should be individualized; doses up to 6 g per day have been administered (per manufacturer).</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Ascor: IV: 200 mg once daily for up to a maximum of 7 days. If no improvement after one week of treatment, retreat until resolution of symptoms is observed.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Oral: 100 to 300 mg daily until body stores are replenished; dose and duration of therapy should be individualized; doses as low as 10 mg may be effective (Hirschmann 1999; Popovich 2009; Weinstein 2001).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b> Wound healing:</b> IM, IV, SubQ: 300 to 500 mg daily for 7 to 10 days pre- and post-operatively; larger doses have also been used</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F136926\" class=\"block dop drugH1Div\"><span class=\"drugH1\">Dosing: Pediatric</span><p>(For additional information <a href=\"topic.htm?path=vitamin-c-ascorbic-acid-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Vitamin C (ascorbic acid): Pediatric drug information&quot;</a>)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Parenteral nutrition, maintenance requirement</b>: IV:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Infants: 15 to 25 mg/kg/day; maximum daily dose: 80 mg/<b>day</b> (ASPEN [Vanek 2012])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Children and Adolescents: 80 mg daily (ASPEN [Vanek 2012])</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Scurvy:</b> Oral, IM, IV, SubQ: Initial: 100 mg/<b>dose</b> 3 times daily for 1 week (300 mg/<b>day</b>) followed by 100 mg once daily until normalization of tissue saturation, usually 1 to 3 months (AAP 2009; Weinstein 2001)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">IV: Ascor:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Infants 5 months to &lt;12 months: 50 mg once daily for up to a maximum of 7 days. <b>Note: </b>Retreatment is not recommended.</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Children &ge;1 year to &lt;11 years: 100 mg once daily for up to a maximum of 7 days. <b>Note: </b>Retreatment is not recommended.</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Children &ge;11 years and Adolescents: Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F136906\" class=\"block doe drugH1Div\"><span class=\"drugH1\">Dosing: Geriatric</span>\n    <p style=\"text-indent:0em;display:inline\">Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F46576213\" class=\"block dor drugH1Div\"><span class=\"drugH1\">Dosing: Renal Impairment</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Mild to severe impairment: There are no dosage adjustments provided in the manufacturer's labeling. Use with caution in patients with renal impairment or patients prone to recurrent renal calculi; may have increased risk of developing acute or chronic oxalate nephropathy.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">ESRD (requiring hemodialysis):</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Adults: IV, Oral: 60 to 100 mg once daily is sufficient to prevent serious ascorbate deficiency due to loss from dialysis; doses &gt;100 mg daily may lead to secondary oxalosis and renal oxalate stone formation (ASPEN [Mueller 2012]; Rolton 1991).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Children and Adolescents: IV, Oral: The KDOQI guidelines for nutrition in children recommend combined dietary and supplement intake should not greatly exceed the age-appropriate dietary reference intake; use caution in providing supplementation (KDOQI 2008).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F46576214\" class=\"block doh drugH1Div\"><span class=\"drugH1\">Dosing: Hepatic Impairment</span>\n    <p style=\"text-indent:0em;margin-left:0em;display:inline\">There are no dosage adjustments provided in the manufacturer's labeling. Based on the pharmacokinetics of ascorbic acid, a water-soluble vitamin, a dosage adjustment does not seem necessary.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F136883\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Capsule Extended Release, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">C-Time: 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Capsule Extended Release, Oral [preservative free]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Crystals, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Vita-C:  (120 g, 480 g) [animal products free, gelatin free, gluten free, lactose free, no artificial color(s), no artificial flavor(s), starch free, sugar free, yeast free]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Liquid, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">BProtected Vitamin C: 500 mg/5 mL (236 mL) [contains propylene glycol, saccharin sodium, sodium benzoate; citrus flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 500 mg/5 mL (473 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Powder, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ascocid:  (227 g)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic:  (113 g, 120 g, 480 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Powder Effervescent, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ascocid-ISO-pH:  (150 g) [corn free, rye free, wheat free]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, Injection: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 500 mg/mL (50 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, Injection [preservative free]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Mega-C/A Plus: 500 mg/mL (50 mL [DSC])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 500 mg/mL (50 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, Injection, as sodium ascorbate [preservative free]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Ortho-CS 250: 250 mg/mL (100 mL [DSC]) [contains edetate disodium, water, sterile]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 250 mg/mL (30 mL [DSC])</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Syrup, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 500 mg/5 mL (118 mL [DSC], 473 mL [DSC])</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Tablet, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Asco-Tabs-1000: 1000 mg [color free, starch free, sugar free]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 100 mg, 250 mg, 500 mg, 1000 mg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Tablet, Oral [preservative free]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 250 mg, 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Tablet Chewable, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Chew-C: 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Fruit C 500: 500 mg [animal products free, gelatin free, gluten free, kosher certified, lactose free, no artificial color(s), no artificial flavor(s), starch free, sugar free, yeast free]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Fruit C: 100 mg [animal products free, gelatin free, gluten free, lactose free, no artificial color(s), no artificial flavor(s), starch free, sugar free, yeast free]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Fruity C: 250 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">VitaChew Vit C Citrus Burst: 125 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 100 mg, 250 mg, 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Tablet Chewable, Oral [preservative free]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">C-500: 500 mg [animal products free, gluten free, soy free, starch free, yeast free]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Tablet Extended Release, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Cemill: 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Cemill SR: 1000 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 500 mg, 1000 mg, 1500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Wafer, Oral [preservative free]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Acerola C 500: 500 mg (50 ea) [corn free, no artificial color(s), no artificial flavor(s), wheat free, yeast free; contains acerola (malpighia glabra)]</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F136867\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">May be product dependent</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F136886\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Oral administration is preferred unless malabsorption is suspected. IM administration is preferred when the parenteral route is required. Oral products may be administered with food.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Injection: For IM (preferred), IV, or SubQ administration. Avoid rapid IV injection; may cause temporary faintness or dizziness.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Ascor: For IV use only. Following dilution in an appropriate IV solution (eg, D5W, SWFI), administer by slow IV infusion at the following rates:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Infants 5 months to &lt;12 months: 1.3 mg/minute</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Children &ge;1 year to &lt;11 years: 3.3 mg/minute</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Children &ge;11 years, Adolescents, and Adults: 33 mg/minute</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F136885\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Ascorbic acid deficiency:</b> Treatment of symptoms of mild deficiency; use in conditions requiring an increased intake (eg, burns, wound healing)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dietary supplement:</b> As a dietary vitamin C supplement</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Scurvy:</b> Prevention and treatment of scurvy</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F3149850\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">International issues:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Rubex [Ireland] may be confused with Brivex brand name for brivudine [Switzerland]</p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Rubex: Brand name for ascorbic acid [Ireland], but also the brand name for doxorubicin [Brazil]</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F136874\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">1% to 10%: Endocrine &amp; metabolic: Hyperoxaluria (with large doses)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">&lt;1%: Diarrhea, dizziness, fatigue, flank pain, flushing, headache, heartburn, nausea, vomiting</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F26111370\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">There are no contraindications listed in the manufacturer's labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F136871\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <i>\n        <b>Concerns related to adverse effects:</b></i></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Oxalate nephropathy/nephrolithiasis: Acidification of the urine by ascorbic acid may cause precipitation of cysteine, urate or oxalate stones. Acute and chronic oxalate nephropathy has been reported with prolonged administration of high IV doses. Patients with renal disease including renal impairment, history of oxalate kidney stones, elderly patients and pediatric patients &lt;2 years of age may be at increased risk. Monitor renal function in patients at increased risk. Discontinue in patients who develop oxalate nephropathy.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Disease-related concerns:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Diabetes: Patients with diabetes mellitus should not take excessive doses for extended periods of time.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Glucose-6-phosphatase dehydrogenase deficiency: Hemolysis has been reported in patients with glucose-6-phosphatase dehydrogenase (G6PD) deficiency and the risk for severe hemolysis may be increased during ascorbic acid therapy. Dose reductions may be necessary along with appropriate monitoring (eg, hemoglobin, blood counts). Discontinue treatment if hemolysis is suspected.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Hemochromatosis: Use with caution in patients with hemochromatosis; excess ascorbic acid intake may increase the risk of adverse events (IOM 2000).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Renal impairment: Use with caution in patients with renal impairment or patients prone to recurrent renal calculi; may have increased risk of developing acute or chronic oxalate nephropathy.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Special populations:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Elderly: Use with caution in the elderly; may be at increased risk for oxalate nephropathy.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Pediatric: Use with caution in the children &lt;2 years of age; may be at increased risk for oxalate nephropathy due to immature kidney function.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Dosage form specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Aluminum: The parenteral product may contain aluminum; toxic aluminum concentrations may be seen with high doses, prolonged use, or renal dysfunction. Premature neonates are at higher risk due to immature renal function and aluminum intake from other parenteral sources. Parenteral aluminum exposure of &gt;4 to 5 mcg/kg/day is associated with CNS and bone toxicity; tissue loading may occur at lower doses (Federal Register 2002). See manufacturer's labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Benzyl alcohol and derivatives: Some dosage forms may contain sodium benzoate/benzoic acid; benzoic acid (benzoate) is a metabolite of benzyl alcohol; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; the &ldquo;gasping syndrome&rdquo; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension, and cardiovascular collapse (AAP [&quot;Inactive&quot; 1997]; CDC 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors 2001); avoid or use dosage forms containing benzyl alcohol derivative with caution in neonates. See manufacturer's labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Injection: Avoid rapid IV injection; may cause temporary faintness or dizziness.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Sodium: Some products may contain sodium; use with caution in sodium restricted patients.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13298776\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F136876\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=9776&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:-2em;margin-left:2em;\">Aluminum Hydroxide: Ascorbic Acid may increase the absorption of Aluminum Hydroxide. <i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Amphetamines: Ascorbic Acid may decrease the serum concentration of Amphetamines. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Bortezomib: Ascorbic Acid may diminish the therapeutic effect of Bortezomib.  Management: Patients should avoid taking vitamin C supplements and vitamin C-containing multivitamins during their bortezomib therapy.  It is probably unnecessary to advise patients to avoid foods/beverages that contain vitamin C (e.g., citrus fruits, etc.).<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Copper: May decrease the serum concentration of Ascorbic Acid. Management: To minimize the risk for ascorbic acid degradation, add multivitamin product to TPN solution immediately prior to infusion or administer multivitamin and copper in separate containers.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">CycloSPORINE (Systemic): Ascorbic Acid may decrease the serum concentration of CycloSPORINE (Systemic). <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Deferoxamine: Ascorbic Acid may enhance the adverse/toxic effect of Deferoxamine. Left ventricular dysfunction is of particular concern.  Management: Avoid ascorbic acid doses greater than 200 mg/day.  Lower doses may be given to patients without cardiac failure, after one month of regular treatment with deferoxamine alone, ideally soon after setting up the infusion pump.  Monitor cardiac function.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Estrogen Derivatives: Ascorbic Acid may increase the serum concentration of Estrogen Derivatives. <i> Risk C: Monitor therapy</i></p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F136879\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">C (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F6789328\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Animal reproduction studies have not been conducted. Maternal plasma concentrations of ascorbic acid decrease as pregnancy progresses due to hemodilution and increased transfer to the fetus. Some pregnant women (eg, smokers) may require supplementation greater than the RDA (IOM 2000).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F21098390\" class=\"block brc drugH1Div\"><span class=\"drugH1\">Breast-Feeding Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Ascorbic acid is present in breast milk; regulatory mechanisms prevent concentrations from exceeding a required amount (IOM 2000). According to the manufacturer, the decision to breastfeed during therapy should take into account the risk of infant exposure, the benefits of breastfeeding to the infant, and benefits of treatment to the mother.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F4844417\" class=\"block dic drugH1Div\"><span class=\"drugH1\">Dietary Considerations</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Some products may contain sodium.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">High dietary sources of ascorbic acid are citrus fruit, tomatoes/tomato juice, and potatoes; also found in other fruits, broccoli, cabbage, cauliflower, spinach, and strawberries. Absorption from diet and supplements is similar (IOM 2000).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dietary recommended adequate intake (AI)</b> (IOM 2000):</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">0 to 6 months: 40 mg daily</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">7 to 12 months: 50 mg daily</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dietary recommended daily allowance (RDA)</b> (IOM 2000): <b>Note: </b>Patients with hemochromatosis, G6PD deficiency, and renal impairment may be at increased risk for adverse effects when exceeding recommended intake limits.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">1 to 3 years: 15 mg daily; upper limit of intake should not exceed 400 mg daily</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">4 to 8 years: 25 mg daily; upper limit of intake should not exceed 650 mg daily</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">9 to 13 years: 45 mg daily; upper limit of intake should not exceed 1,200 mg daily</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">14 to 18 years: Upper limit of intake should not exceed 1,800 mg daily</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Males: 75 mg daily</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Females: 65 mg daily</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Pregnant females: 80 mg daily; upper limit of intake should not exceed 1,800 mg daily</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Lactating females: 115 mg daily; upper limit of intake should not exceed 1,800 mg daily</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&gt;18 years: Upper limit should not exceed 2,000 mg daily</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Males: 90 mg daily</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Females: 75 mg daily</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Pregnant females: 19 to 50 years: 85 mg daily</p>\n    <p style=\"text-indent:-2em;margin-left:8em;\">Lactating females: 19 to 50 years: 120 mg daily</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Adult smoker: Add an additional 35 mg daily</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50802193\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;display:inline\">Renal function (patients at risk for developing oxalate nephropathy/nephrolithiasis); hemoglobin and blood counts (patients with G6PD deficiency).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F136870\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Ascorbic acid is an essential water soluble vitamin that acts as a cofactor and antioxidant. Ascorbic acid is an electron donor used for collagen hydroxylation, carnitine biosynthesis, and hormone/amino acid biosynthesis. It is required for connective tissue synthesis as well as iron absorption and storage (IOM 2000).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F136888\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Onset of action: Reversal of scurvy symptoms: 2 days to 3 weeks </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Absorption: Oral: Readily absorbed in the intestine; an active process thought to be saturable and dose dependent (30 to 180 mg/day: 70% to 90%; &gt;1,000 mg/day: &le;50%) (IOM 2000)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Bioavailability: Oral: For doses up to 200 mg, nearly 100%; declines with increasing doses with ~33% for a single dose of 1250 mg (Schwedhelm 2003)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Distribution: Pituitary and adrenal glands, leukocytes, eye tissues and humors, and brain; lower concentrations in the plasma and saliva (IOM 2000)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Metabolism: Reversibly oxidized to dehydroascorbic acid (DHA); both ascorbic acid and DHA are active. Unabsorbed ascorbic acid is degraded in the intestine (IOM 2000)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Half-life elimination: 10 hours (Schwedhelm 2003). Biological half-life: 8 to 40 days (IOM 2000)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Excretion: Urine (with high serum concentrations) (IOM 2000); there is an individual specific renal threshold for ascorbic acid; when blood levels are high, ascorbic acid is excreted in urine, whereas when the levels are subthreshold (doses up to 80 mg/day) very little if any ascorbic acid is excreted into urine </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F6133143\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Chewable</b> (Vitamin C Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">500 mg (100): $4.79</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (BProtected Vitamin C Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">500 mg/5 mL (236 mL): $14.99</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Ascorbic Acid Injection)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">500 mg/mL (50 mL): $102.08</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablet, controlled release</b> (Cemill Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">500 mg (100): $6.48</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablet, controlled release</b> (Cemill SR Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1000 mg (100): $8.64</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Ascorbic Acid Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">250 mg (100): $4.18</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">500 mg (100): $4.38</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Wafer</b> (Acerola C 500 Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">500 mg (50): $3.29</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F136891\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Addivita (IT);</li>\n      <li>Appeton Activ-C (MY);</li>\n      <li>Ascofer (LU);</li>\n      <li>Asconvita (PH);</li>\n      <li>Ascorbin (PH);</li>\n      <li>Ascorbovit (QA);</li>\n      <li>Ascormin (TW);</li>\n      <li>Ascorvit (DE);</li>\n      <li>Askorbin (ID);</li>\n      <li>Askorbinsyre &ldquo;Dak&rdquo; (DK);</li>\n      <li>Biferce (ID, SG);</li>\n      <li>Biovital Vitamin C (HU);</li>\n      <li>C Vitamin Pharmavit (HU);</li>\n      <li>C-Dose (BE);</li>\n      <li>C-Tabs (LK);</li>\n      <li>C-Vimin (FI, NO, SE);</li>\n      <li>C-Vital (LB, SA);</li>\n      <li>C-Will (BE, LU, TH);</li>\n      <li>Ce-Vi-Sol (CR, DO, GT, HN, NI, PA, PH, SV);</li>\n      <li>Cebion (AE, AT, BH, CL, CY, EG, ES, GR, IL, IQ, IR, IT, JO, KW, LB, LY, OM, PE, PL, PT, QA, SA, SY, YE);</li>\n      <li>Cecai (TW);</li>\n      <li>Cecap (HK);</li>\n      <li>CeCe (KR);</li>\n      <li>Cecon (BB, BM, BS, BZ, GY, JM, PH, PR, SR, TT);</li>\n      <li>Cecon Drops (AU);</li>\n      <li>Ceelin (SG, VN);</li>\n      <li>Ceevit (LK);</li>\n      <li>Celaskon (CZ);</li>\n      <li>Celin (IN);</li>\n      <li>Celon (BE);</li>\n      <li>Cenol (LU);</li>\n      <li>Cetamine (BE, LU);</li>\n      <li>Cetebe (AT, BG, CH, HU);</li>\n      <li>Cetrinets (MY);</li>\n      <li>Cevalin (MX);</li>\n      <li>Cevi Drops (LU);</li>\n      <li>Cevidrops (BE);</li>\n      <li>Cevitil (QA);</li>\n      <li>Cevitol (AT);</li>\n      <li>Cewin (BR);</li>\n      <li>Chewette C (HK);</li>\n      <li>Citravite (IN, NZ);</li>\n      <li>Dayvital (NL);</li>\n      <li>Femiprim (MX);</li>\n      <li>Fit-C (ID);</li>\n      <li>Flavettes (SG);</li>\n      <li>Hicee (JP);</li>\n      <li>Larce (ID);</li>\n      <li>Leder C (TW);</li>\n      <li>Limcee (IN);</li>\n      <li>Nutravit C (PH);</li>\n      <li>Nutricee (PH);</li>\n      <li>Ophtavit C (BE, LU);</li>\n      <li>Plivit C (HR);</li>\n      <li>Pro-C (AU);</li>\n      <li>Redoxon (AE, AR, AT, AU, BE, BH, BR, CH, CO, CY, EC, EG, ES, FI, GB, GR, IL, IQ, IR, IT, JO, KW, LB, LU, LY, OM, PE, PT, PY, QA, SA, SY, TR, UY, VE, YE);</li>\n      <li>Redoxon C (BB, BF, BJ, BM, BS, BZ, CI, ET, GH, GM, GN, GY, JM, KE, LR, MA, ML, MR, MU, MW, NE, NG, PR, SC, SD, SL, SN, SR, TN, TT, TZ, UG, ZM, ZW);</li>\n      <li>Redoxon Forte (EC, IN);</li>\n      <li>Rubex (IE);</li>\n      <li>Scorbex (ZA);</li>\n      <li>Scorbi-100 (LK);</li>\n      <li>Sicovit C (RO);</li>\n      <li>Sweetcee (TH);</li>\n      <li>Tanvimil-C (AR);</li>\n      <li>Teddy-C (TH);</li>\n      <li>Tropicee (PH);</li>\n      <li>Upha C (MY);</li>\n      <li>Upsa-C (AE, BE, BH, CY, EG, IL, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);</li>\n      <li>Vamcee (PH);</li>\n      <li>Vicef (BF, BJ, CI, ET, GH, GM, GN, KE, LR, MA, ML, MR, MU, MW, NE, NG, SC, SD, SL, SN, TN, TZ, UG, ZM, ZW);</li>\n      <li>Vit'C (BE);</li>\n      <li>Vita-C (JO);</li>\n      <li>Vita-Cedol Orange (BB, BM, BS, BZ, GY, JM, PR, SR, TT);</li>\n      <li>Vitac (CL);</li>\n      <li>Vitamin C (HR, HU);</li>\n      <li>Vitamine C Lambo (BE);</li>\n      <li>Vitamine C OJG (BE);</li>\n      <li>Vitamine C Repha (BE);</li>\n      <li>Vitamine C Roter (LU);</li>\n      <li>Vitamine-C-Qualiphar (LU);</li>\n      <li>Vitascorbol (FR);</li>\n      <li>Vitonic (LU);</li>\n      <li>Vorange (HK, MY, SG);</li>\n      <li>Xon-ce (ID);</li>\n      <li>&Aacute;cido asc&oacute;rbico (MX)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. <i>J Pediatr</i>. 2001;139(2):317-319.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-c-ascorbic-acid-drug-information/abstract-text/11487763/pubmed\" target=\"_blank\" id=\"11487763\">11487763</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Aluminum in large and small volume parenterals used in total parenteral nutrition. <i>Fed Regist</i>. 2002;67(244):77792-77793.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    American Academy of Pediatrics Committee on Nutrition. Micronutrients: vitamin K. <i>Pediatric Nutrition Handbook.</i> 6th ed, Kleinman RE, ed, Elk Grove Village, IL: American Academy of Pediatrics, 2009, 484.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Antman EM, Anbe SC, Alpert JS, et al, &ldquo;ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction - Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction),&rdquo; Circulation, 2004, 110(5):588-636. Available at http://www.circulationaha.org/cgi/content/full/110/5/58815289388</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ascor (ascorbic acid) [prescribing information]. Santa Ana, CA: McGuff Pharmaceuticals, Inc; October 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    A.S.P.E.N. Adult Nutrition Support Core Curriculum. 2nd edition. Mueller CM, ed. 2012. http://www.nutritioncare.org.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol&mdash;United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982;31(22):290-291. <a href=\"http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm\" target=\"_blank\">http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm</a><span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-c-ascorbic-acid-drug-information/abstract-text/6810084/pubmed\" target=\"_blank\" id=\"6810084\">6810084</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Giunta JL, &ldquo;Dental Erosion Resulting From Chewable Vitamin C Tablets,&rdquo; <i>J Am Dent Assoc</i>, 1983, 107(2):253-6.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-c-ascorbic-acid-drug-information/abstract-text/6578267/pubmed\" target=\"_blank\" id=\"6578267\">6578267</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Hirschmann JV, Raugi GJ. Adult scurvy. <i>J Am Acad Dermatol</i>. 1999;41(6):895-906; quiz 907-10.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-c-ascorbic-acid-drug-information/abstract-text/10570371/pubmed\" target=\"_blank\" id=\"10570371\">10570371</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    &quot;Inactive&quot; ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics (AAP) Committee on Drugs. <i>Pediatrics</i>. 1997;99(2):268-278.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-c-ascorbic-acid-drug-information/abstract-text/9024461/pubmed\" target=\"_blank\" id=\"9024461\">9024461</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    IOM (Institute of Medicine), <i>Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids</i>, Washington, DC: National Academy Press, 2000.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Korallus U, Harzdorf C, and Lewalter J, &ldquo;Experimental Basis for Ascorbic Acid Therapy of Poisoning by Hexavalent Chromium Compounds,&rdquo; <i>Int Arch Occup Environ Health</i>, 1984, 53(3):247-56.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-c-ascorbic-acid-drug-information/abstract-text/6706420/pubmed\" target=\"_blank\" id=\"6706420\">6706420</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Lawton JM, Conway LT, Crosson JT, et al, &ldquo;Acute Oxalate Nephropathy After Massive Ascorbic Acid Administration,&rdquo; <i>Arch Intern Med</i>, 1985, 145(5):950-1.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-c-ascorbic-acid-drug-information/abstract-text/3994472/pubmed\" target=\"_blank\" id=\"3994472\">3994472</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    McAllister CJ, Scowden EB, Dewberry FL, et al, &ldquo;Renal Failure Secondary to Massive Infusion of Vitamin C,&rdquo; <i>JAMA</i>, 1984, 252(13):1684.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    National Kidney Foundation. KDOQI clinical practice guideline for nutrition in children with CKD: 2008 update. <i>American Journal of Kidney Diseases</i>. 2009;53(3, Supplement 2):S11-S104.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Perrone G, Hideshima T, Ikeda H, et al, &ldquo;Ascorbic Acid Inhibits Activity of Bortezomib <i>in vivo</i>,&rdquo; <i>Leukemia</i>, 2009, 23(9):1679-86.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-c-ascorbic-acid-drug-information/abstract-text/19369963/pubmed\" target=\"_blank\" id=\"19369963\">19369963</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Popovich D, McAlhany A, Adewumi AO, Barnes MM. Scurvy: forgotten but definitely not gone. <i>J Pediatr Health Care</i>. 2009;23(6):405-415. doi:10.1016/j.pedhc.2008.10.008. Epub 2009 Feb 10.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-c-ascorbic-acid-drug-information/abstract-text/19875028/pubmed\" target=\"_blank\" id=\"19875028\">19875028</a>]</span><span class=\"doi\">10.1016/j.pedhc.2008.10.008</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Pru C, Eaton J, and Kjellstrand C, &ldquo;Vitamin C Intoxication and Hyperoxalemia in Chronic Hemodialysis Patients,&rdquo; <i>Nephron</i>, 1985, 39(2):112-6.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-c-ascorbic-acid-drug-information/abstract-text/3974772/pubmed\" target=\"_blank\" id=\"3974772\">3974772</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Rolton HA, McConnell KM, Modi KS, Macdougall AI. The effect of vitamin C intake on plasma oxalate in patients on regular haemodialysis. <i>Nephrol Dial Transplant</i>. 1991;6(6):440-443.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-c-ascorbic-acid-drug-information/abstract-text/1876286/pubmed\" target=\"_blank\" id=\"1876286\">1876286</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Schwedhelm E, Maas R, Troost R, B&ouml;ger RH. Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stress. <i>Clin Pharmacokinet</i>. 2003;42(5):437-459.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-c-ascorbic-acid-drug-information/abstract-text/12739983/pubmed\" target=\"_blank\" id=\"12739983\">12739983</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Tunget CL, Clark RF, Manoguerra AS, et al, &ldquo;Iron Overdose and Detection of Gastrointestinal Bleeding With the Hemoccult&reg; and Gastroccult&reg; Assays,&rdquo; <i>Ann Emerg Med</i>, 1995, 26(1):54-7.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-c-ascorbic-acid-drug-information/abstract-text/7793721/pubmed\" target=\"_blank\" id=\"7793721\">7793721</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Vanek VW, Borum P, Buchman A, et al. A.S.P.E.N. Position paper: recommendations for changes in commercially available parenteral multivitamin and multi-trace element products. <i>Nutr Clin Pract. </i>2012;27(4):440-491.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-c-ascorbic-acid-drug-information/abstract-text/22730042/pubmed\" target=\"_blank\" id=\"22730042\">22730042</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Weinstein M, Babyn P, Zlotkin S. An orange a day keeps the doctor away: scurvy in the year 2000. <i>Pediatrics</i>. 2001;108(3):E55.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/vitamin-c-ascorbic-acid-drug-information/abstract-text/11533373/pubmed\" target=\"_blank\" id=\"11533373\">11533373</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 9776 Version 178.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F136900\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F136901\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F136950\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F136905\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Pediatric\" href=\"#F136926\" class=\"outlineLink\">Dosing: Pediatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Geriatric\" href=\"#F136906\" class=\"outlineLink\">Dosing: Geriatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Renal Impairment\" href=\"#F46576213\" class=\"outlineLink\">Dosing: Renal Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Hepatic Impairment\" href=\"#F46576214\" class=\"outlineLink\">Dosing: Hepatic Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F136883\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F136867\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F136886\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F136885\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F3149850\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F136874\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F26111370\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F136871\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13298776\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F136876\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F136879\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F6789328\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Breast-Feeding Considerations\" href=\"#F21098390\" class=\"outlineLink\">Breast-Feeding Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Dietary Considerations\" href=\"#F4844417\" class=\"outlineLink\">Dietary Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F50802193\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F136870\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics\" href=\"#F136888\" class=\"outlineLink\">Pharmacodynamics/Kinetics</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F6133143\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F136891\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/9776|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=vitamin-c-ascorbic-acid-patient-drug-information\" class=\"drug drug_patient\">Vitamin C (ascorbic acid): Patient drug information</a></li><li><a href=\"topic.htm?path=vitamin-c-ascorbic-acid-pediatric-drug-information\" class=\"drug drug_pediatric\">Vitamin C (ascorbic acid): Pediatric drug information</a></li></ul></div></div>","javascript":null}